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ABSTRACT
Background: Transrectal prostate biopsy (TRbx) transfers colonic bacteria into prostatic tissue, poten-
tially causing infectious complications, including sepsis. Our objective was to determine whether
biopsy needle shape, surface properties and sampling mechanism affect the number of bacteria trans-
ferred through the colon wall, and evaluate a novel needle with improved properties.
Methods: The standard Tru-Cut biopsy needle used today was evaluated for mechanisms of bacterial
transfer in a pilot study. A novel Tru-Cut needle (Forsvall needle prototype) was developed. TRbx was
simulated using human colons ex-vivo. Four subtypes of the prototype needle were compared with a
standard Tru-Cut needle (BARD 18G). Prototype and standard needles were used to puncture 4 differ-
ent colon specimens in 10 randomized sites per colon. Needles were submerged into culture media to
capture translocated bacteria. The media was cultured on blood agar and then the total amount of
transferred bacteria was calculated for each needle. The primary outcome measure was the percent
reduction of bacteria translocated by the prototype needles relative to the standard needle. Secondary
outcome measures were the effects of tip design and coating on the percent reduction of translocated
bacteria.
Results: Prototype needles reduced the number of translocated bacteria by, on average, 96.0% (95%
confidence interval 93.0-97.7%; p< 0.001) relative to the standard needle. This percent reduction was
not significantly affected by prototype needle tip style or surface coating.
Conclusions: The Forsvall needle significantly reduces colonic bacterial translocation, suggesting that
it could reduce infectious complications in prostate biopsy. A clinical trial has been initiated.
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Background
Prostate cancer is mainly diagnosed and monitored using tis-
sue obtained by a Tru-Cut biopsy needle [1]. Transrectal
prostate biopsy (TRbx) is the most common biopsy method
[1]. In TRbx, the biopsy needle transfers colonic bacteria
through the rectal wall into the prostate and periprostatic
tissue, potentially causing infectious complications, including
sepsis [1–3]. Currently, the risk of post-biopsy infection is
2–10% [1,4]. Although the use of pre-biopsy MRI, nomo-
grams and biomarkers has reduced the need for prostate
biopsies, huge numbers of men still undergo a prostate
biopsy. Antibiotic prophylaxis reduces the risk of post-biopsy
infection and is routinely used, but antimicrobial resistance
has led to increasing rates of infections [1,5]. Current recom-
mendations of antibiotic prophylaxis vary [1,6]. Escherichia
coli (E. coli) is by far the most common bacterium isolated
from patients with post-TRbx sepsis [7].
In addition to standard antibiotic prophylaxis, methods to
reduce infections after prostate biopsy include rectal swab
cultures to individualize antibiotic prophylaxis, pre-biopsy
rectal cleansing, and using the transperineal route for biopsy.
However these methods are expensive, time consuming,
introduce new side effects, or highly uncomfortable [1,8]. We
are unaware of any attempts to reduce infectious complica-
tions by modifying the needle design or surface properties,
even though infections are caused by the needle pushing
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bacteria into the tissue [3]. Our hypothesis is that if bacterial
transfer can be minimized, the risk of infection will decrease.
In this study, we first aimed to examine physical properties
of the standard Tru-Cut needle that can lead to bacterial
transfer. We thereafter developed a needle with physical and
mechanical properties designed to reduce the number of
bacteria (bacterial load) transferred across the rectal wall to
the prostate. Finally, we evaluated the needle’s performance
in an ex-vivo study.
Materials and methods
Pilot study
The mechanism of action of the standard Tru-Cut needle is
described in Figure 1(A). We hypothesized that the Tru-Cut
needle’s forward-facing opening and rough, highly echogenic
part may facilitate collection and deposition of bacteria into
the tissue. To test this hypothesis, we conducted a pilot
study using steel rods with grinded tips to simulate a closed
needle with perfect fit between the needle parts. These rods
are referred to as rod prototype needles. We punctured a
simulated colon wall consisting of bovine meat covered with
faeces from a healthy human and the number of translo-
cated bacteria were measured. Matrix-assisted laser desorp-
tion/ionization-time of flight mass spectrometry (MALDI-TOF
MS) was used to determine the most common types of bac-
teria species translocated by the needles. Method details are
in supplement A.
Forsvall needle prototype
Based on the results of the pilot study, we constructed an
operational two-part biopsy needle with a closed tip, and a
Figure 1. Ex vivo biopsy simulation method with standard needle and Forsvall needle prototypes. (A) Schematic depiction of standard Tru-Cut biopsy needle mech-
anism. (B) Schematic depiction of Forsvall needle biopsy mechanism. (C) The five needles used in the ex vivo simulation were a standard 18 G Tru-Cut needle (Bard)
and four versions of the Forsvall 18 G stainless steel needle prototype: Facetted tip with no coating, facetted tip with goldþ PEG coating, pencil point tip with no
coating, and pencil point tip with goldþ PEG coating. Note that the opening of the Tru-Cut needle is in the direction of travel, the opening of the Forsvall needle
is in a 90-degree angle to the direction of travel. In the ex-vivo simulation the needles were used in this same order until all punctures were completed. (D)
Schematic depiction of the experimental workflow. First, fresh colons were obtained after colon cancer surgery and opened to form a 5 8cm rectangle. This rect-
angular piece of colon was then mounted on a special bracket with the mucosal side up. A randomization pallet consisting of 50 evenly spaced holes labelled A–E
and 1–10 was mounted over the colon. A card was drawn from a randomization deck of playing cards with labels corresponding to the holes on the randomization
pallet. The corresponding hole was then punctured with the next needle in the series. The needle was immediately submerged in a tube filled with culture media
to a depth of 6 cm, opened and closed to dislodge any collected material, and then removed. The culture media was plated on a code-labelled blood agar plate
and incubated overnight, and the number of colonies was counted blindly to avoid bias. (E) Photograph of a colon mounted on the bracket with the randomization
pallet placed on top, as viewed from above.
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semi-automatic biopsy gun mechanism designed to force the
two parts of the needle together, resulting in a smooth nee-
dle surface (Figure 1(B)). The resulting needle was named the
Forsvall needle prototype after its inventor, hereafter referred
to as the prototype needle.
We tested four versions of the prototype needle: facetted
or pencil point tip, both with and without PEG (Polyethylene
Glycol) coating. PEG may inhibit bacterial adherence to surfa-
ces and is already safely used in humans in drug delivery
systems [9] and as a rectal spacer during prostate cancer
radiotherapy [10]. The PEG prototype needles were coated
with a 100 nm gold film, to which PEG (10 kg/mol) was
covalently bonded by 50min soaking in 0.3 g/L PEG solu-
tion [11].
Ex vivo randomized study
We used an ex-vivo human colon model to simulate bacterial
transfer in TRbx. We compared the four prototype needles
(Figure 1(C)) to each other and to a common Tru-Cut needle
(BARD 18 Gauge, 20 cm Tru-Cut needle for MAGNUM biopsy
gun; referred to as the standard needle).
Patient material
The study was approved by the Ethical Review Board in
Lund (Dnr: 2016/273) and informed consent was obtained
from all patients prior to surgery. We obtained four human
colon specimens, immediately after they had been resected
during surgery for colon cancer. Patient and colon character-
istics are described in Table 1. Colons with any other disease,
such as diverticulosis, were excluded. Removed colons were
rinsed with water according to standard surgical procedures
and the 5 cm of the colon furthest from the tumour was cut
off and opened to form a rectangle of about 5 8 cm.
Pericolic fat was removed. Care was taken to avoid contami-
nating the outside of the colon. The colon was mounted on
a special bracket with the mucosal side up and slightly
stretched to achieve equal tension across the section. No vis-
ible faecal matter was present. A randomization pallet with
50 evenly spaced holes labelled A-E and 1-10 (Figure 1(D
and E)) was mounted over the colon. Because colon tissue
necrotizes after 4–6 h of ischaemia [12], all experiments were
finished within 3 h after colon removal.
Randomization
The five needles were used in the same order throughout
the experiment, ensuring that each needle was used for
every fifth puncture. The puncture site was randomized using
50 playing cards, each with a code corresponding to a hole
in the randomization pallet. The deck was shuffled for 5min
and prior to each puncture the top card was drawn. The
puncture was randomized to the corresponding location
(Figure 1(C–E)).
Colon puncture and bacterial capture
We have observed that a 20 cm needle reaches a maximum
depth of 6 cm into the body when obtaining TRbx. Therefore
after each puncture, but before it was removed from the
colon specimen, the needle was submerged to a depth of
6 cm into a tube containing 9.4mL Brain Heart Infusion
medium (BHI) that was held below the colon. While sub-
merged, the needle was agitated, opened, and closed for 4 s
to release any attached material. To ensure sterility between
punctures, a new sterile Bard needle was used each time.
The four prototype needles were sterilized by wiping, soaked
twice in ethanol, rinsed twice with distilled water, and finally
dried with a sterile cloth.
In systematic TRbx, 10–12 punctures are done with the
same needle. To simulate a full TRbx procedure, we addition-
ally did 10 subsequent punctures in one colon without steri-
lizing the needles in-between. A previously un-punctured
section of colon 4 was used, and puncture sites were
randomized as above. In this experiment we compared the
standard needle to the PEG-coated pencil tip proto-
type needle.
Quantitative bacterial culture
The tubes with collected bacteria were vortexed to get a sin-
gle-cell suspension of the bacteria, and 100 lL of each solu-
tion was plated on blood agar plates. The plates were coded
and incubated overnight at 37 C in 5% CO2. The number of
colony-forming units (CFU) on each plate was counted
blindly by a technician to prevent bias. The total number of
bacteria translocated by each puncture was calculated from
the CFU in 100 mL multiplied by the total volume of culture
medium (9.4mL) used to capture the bacteria. Each CFU was
considered to originate from one viable bacterium [13].
Table 1. Baseline characteristics of patients and colon specimens.
Patient 1 Patient 2 Patient 3 Patient 4
Colon tissue used Transversum Transversum Transversum Sigmoideum
Surgery Right side hemicolectomy Right side hemicolectomy Right side hemicolectomy Sigmoid resection
Age 88 80 72 77
Sex Female Female Female Male















1927 6223 55883 13921
All surgery was for colon cancer.
TMP: Trimethoprim; SMX: Sulfamethoxazole; po: per oral; iv: intra venous.
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Statistical analysis
To compare the number of bacterial colonies translocated by
each needle, we used generalized linear mixed-effects mod-
els with a negative binomial distribution and a random inter-
cept at the individual colon level as our main statistical
method. We did this because the number of bacterial colo-
nies (count data) displayed over-dispersion and colons were
punctured repeatedly, representing data non-independency.
Model assumptions were checked using qq-normal plots and
histograms on deviance residuals. Results are reported as a
percent reduction and presented with 95% confidence inter-
vals (95% CI) and p values below 0.05 were regarded as stat-
istically significant. To compare the effect of subsequent
punctures without sterilization of the needle in between, we
used an unpaired t-test to compare the number of bacteria
translocated per puncture by each needle. Statistical analyses




To determine whether the needles’ surface properties affect
bacterial translocation during TRbx, we punctured a simu-
lated colon with three standard Tru-Cut needles and 10
versions of the rod prototype needle (steel rods with grinded
tips with different surface coatings). Light microscopy images
of the standard Tru-Cut needles after puncture indicated that
faecal matter was collected in the opening between the
inner and outer needle and also on the rough hyperecho-
genic zone (Figure 2(A) and Supplementary Figure 1). The
rod prototype needles with low bacterial count had no vis-
ible faecal matter collection (Figure 2(B)).
Uncoated, electropolished, gold-coated, and PEG-coated
rod prototype needles translocated 98.7% less bacteria than
the Tru-Cut needles (Figure 2(C)). Prototype needles coated
with silicon nitride or PLL-g-PEG on silicon nitride did not
reduce the number of translocated bacteria, indicating that
this coating may have facilitated bacterial adhesion to the
surface. MALDI-TOF MS analysis of 300 random colonies
identified all 300 (100%) isolates to be E. coli.
Ex vivo randomized study
To determine whether the prototype needle can reduce bac-
terial translocation relative to the standard Tru-Cut needle,
we tested fully openable versions of the prototype needle
using ex vivo human colons to simulate TRbx as realistically
as possible. We examined the needles by light microscopy
and found that the standard Tru-Cut needle collected visible
faecal matter in the forward-facing opening between inner
Figure 2. Effect of physical properties and needle coating on bacterial translocation in a pilot experiment. (A) Representative images of a standard Tru-Cut biopsy
needle (Mermaid 18 G) after a puncture through a simulated colon. Left images show the gap between the inner and outer needle in a closed (top) and opened
(bottom) state. Right image shows the rough, highly echogenic area, used for enhancing ultrasound reflection and visualization of the needle within the body in
other types of biopsy. The highly echogenic area has no use in TRbx because a needle guide is used to locate the needle tip. Arrows indicate areas of visible faecal
matter and tissue collection. (B) Goldþ PEG coated rod prototype needle after puncture of a piece of meat covered in faecal matter, simulating the rectal wall. No
foreign matter was visible at this magnification. (C) Number of bacterial colonies translocated when a piece of meat covered in faecal matter was punctured with
three different standard Tru-Cut needles and ten versions of the rod prototype needle with different combinations of surface coatings. The average bacteria translo-
cated by all three standard needles (pooled) was set to 100% and the percentage translocated by each rod prototype needle was calculated relative to
this number.
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and outer needles (Figure 3(A)), while the prototype needles
did not collect any visible faecal matter (Figure 3(B)).
The prototype needles carried, on average, 96.0% fewer
bacteria (95% CI: 93.0 to 97.7%, p< 0.0001) across the colon
than the standard needle did (Table 2). The reduction in
translocated bacteria was similar for all prototype needles
regardless of tip style and the presence or absence of PEG
coating (Table 2). Although the number of bacteria collected
by the Tru-Cut needle differed between colons (Table 1,
Figure 3(C)), this did not affect bacterial reduction by the
Figure 3. Standard Tru-Cut needle and prototype needle after puncture through an ex vivo human colon. (A) Representative images of the gap between the inner
and outer needle parts of a standard 18 G Tru-Cut needle (Bard 18 G) when closed and partially open, following puncture of an ex-vivo human colon. White arrows
indicate areas of visible fecal matter and tissue collection. Red line in the ‘open’ image indicates the position of the outer needle when closed, please note the
extensive visual contamination. (B) Representative images of a 18 G Forsvall needle prototype (pencil tip with goldþ PEG) following puncture with of an ex-vivo
human colon, images show corresponding locations to images in A, closed and partially open. No foreign matter was visible at this magnification. (C) Mean number
of colonies (CFU) translocated per puncture through each colon by the four Forsvall needle prototypes and the standard Tru-Cut needle. Percentages are indicated
above each bar with the mean bacteria translocated by the standard needle set as 100% for each colon.
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prototype needles (94-98% reduction for each colon,
Figure 3(C)).
We also compared bacterial translocation by one proto-
type needle (pencil point tip and PEG coating) and the
standard needle in 10 subsequent punctures without steril-
ization. The prototype needle carried 94.0% (p< 0.0001)
fewer bacteria than the standard Tru-Cut needle across all
punctures, which was similar to the 96% reduction we found
when using the standard protocol.
Discussion
In this study, we explored the effect of biopsy needle design
on bacterial translocation across the rectal wall in an experi-
mental model, simulating TRbx. We identified design issues
with the standard Tru-Cut needle related to bacterial trans-
location, and developed a novel needle with the aim to
reduce bacterial translocation into the prostate at TRbx. Our
results indicate that when a TRbx is performed, most of the
bacteria that are transferred through the rectal wall are col-
lected in the forward-facing gap between the inner and
outer parts of the Tru-Cut needle (Figure 4). The Tru-Cut nee-
dle design thus enables bacterial translocation and subse-
quent infection.
The Forsvall needle prototype significantly reduced bac-
terial translocation across the colon wall by 96% relative to
the standard Tru-Cut biopsy needle. The two parts of the
Forsvall needle are forced closed, resulting in a streamlined
design without edges that minimizes the collection of for-
eign matter (bacteria and devitalized tissue) as the needle
moves through the tissue. The results of our study indicate
that the Forsvall needle may reduce the risk of post-TRbx
infections. The association between bacterial load reduction
and infection reduction has been shown in studies of pre-
biopsy povidone iodine cleansing. In a quantitative bacterial
study, extensive povidone-iodine cleansing reduced the bac-
terial load in the rectum by 97.2% and reduced the rate of
infections from 4.3 to 0.6% [8]. A meta-analysis showed that
povidone-iodine cleansing reduced the risk of infections by
42% (95% CI 24–57%) [14]. Although cheap, povidone-iodine
cleansing may lead to allergic reactions, is time-consuming
and uncomfortable for the patient, and its efficacy may be
Table 2. Percent reduction of translocated bacteria for each variation of the Forsvall prototype needle, as well as the four proto-
type needles grouped, relative to the standard Tru-Cut needle (BARD 18 Gauge 20 cm Tru-Cut biopsy needle for MAGNUM
biopsy gun).
Needle type Bacterial reduction, % (95 %CI) p Value
All prototype needles vs Tru-Cut 96.0 (93.0-97.7) <0.001
Facetted tip vs Tru-Cut 96.2 (91.9-98.2) <0.001
Facetted tipþ PEG vs Tru-Cut 94.5 (88.5-97.3) <0.001
Pencil point tip vs Tru-Cut 97.7 (94.9-99.0) <0.001
Pencil point tipþ PEG vs Tru-Cut 96.4 (92.4-98.3) <0.001
Pencil point tipþ PEG vs Tru-Cut (subsequent punctures) 94.0 (85.5-97.5) <0.001
Uncoated vs PEG coated 38% 0.294
Pencil point vs facetted tip 29% 0.247
Figure 4. Schematic depiction of TRbx and bacteria/fecal matter deposition when using a standard tru cut needle (left) and the Forsvall needle prototype (right).
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user dependent. Hence, this approach is not in widespread
use. Our prototype needle reduced the translocated bacterial
load to a similar extent. Compared with povidone-iodine, use
of the Forsvall needle is not time-consuming, not expected
to increase discomfort or side effects and is not user
dependent. It also visually reduces translocation of devital-
ized tissue that may be a possible substrate for bacterial
growth and later clinical infection. Needles with either facet
or pencil point tip design, with or without PEG coating, were
all equally efficient at reducing bacterial transfer indicating
that the smooth needle surface, achieved through the closed
needle design and special biopsy gun mechanism, is the
most important factor for reducing bacterial translocation.
Bacterial transfer may be further reduced by improved preci-
sion in manufacturing, material choice, or other surface treat-
ments or coatings. The highly echogenic area on Tru-Cut
needles has no use in TRbx because the biopsy guide on the
ultrasound handle ensures that the needle is in focus and
clearly visible.
We hypothesized that PEG coating would decrease bacter-
ial adhesion to the needles, as PEG coating creates an inert
surface by creating a steric barrier [11], but our results do
not support this hypothesis. A tentative explanation may be
that, because the PEG brush only prevents surface adhesion
forces operating on the nanoscale, it is unable to stop bac-
teria from being present on top of the coating. The rough-
ness of the surface also plays a critical role since a PEG
coating, tens of nanometres in thickness, cannot prevent
bacteria form attaching in crevices on the metal surface that
appear on the microscale. In repeat biopsy without cleaning
the needle, which may better represent a prostate biopsy,
the Forsvall needle also reduced bacterial load by 94%.
Strengths of this study include the use of human tissue to
simulate a TRbx, the use of randomization and blinding dur-
ing analysis to reduce bias, and consistent results for micros-
copy findings and bacterial culture analysis. There are,
however, also some limitations. The patients preoperatively
received antibiotics: Metronidazole with Trimethoprim/
Sulfamethoxazole (TMP/SMX) or with Cefotaxime. TMP/SMX
is sometimes used as prophylaxis in TRbx, but rarely
Cefotaxime. The antibiotic resistance patterns of the bacterial
flora in the colon tissue were not analysed and the effect of
the prophylaxis was therefore not evaluated. On the other
hand, the preoperative metronidazole should not change the
interpretation of the results as anaerobes rarely cause infec-
tion after TRbx [7]. Moreover, the properties of an ex-vivo
colon may differ from those of an in-vivo colon, as the tissue
may degrade and change its properties over time. The colon
parts used may also differ from the properties of the rectum,
particularly as the colon was stretched and thus slightly thin-
ner than normal. Moreover, the colon specimens were
cleared of all pericolic fat to ensure even thickness, but a
TRbx needle typically passes through 2–5mm of fatty tissue
separating the colon and the prostate. Finally, the medium
that we used was not solid, so it did not perfectly simulate a
prostate biopsy. We hypothesise that, since almost all bac-
teria are trapped inside the Tru-Cut needle, the number of
bacteria is not affected by its passage through periprostatic
tissue. It will thus deliver its bacterial load into the prostate
when the needle is opened to collect the specimen.
Therefore, and due to the short exposure time, stirring and
opening and closing the needle in the liquid medium after
the puncture, would accurately capture the bacteria trapped
in and on the needle.
We believe that the differences in bacterial load between
the colon specimens were related to intra- and inter-patient
variations in the colon contents, differences in the process of
rinsing the colon mucosa, and possibly also by differences in
bacterial antibiotic resistance between patients. Nonetheless,
the results were consistent despite these possible
differences.
In conclusion, we have shown that a smooth, forced-
closed needle design significantly reduces bacterial transfer
across the rectal wall in TRbx and is therefore likely to
reduce the risk of infectious complications in TRbx. A clinical
trial evaluating the quality of prostate specimens obtained
by the Forsvall needle has been completed [15] and its abil-
ity to reduce infectious complications will be studied further
in a prospective, randomized multicentre trial.
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